文献速递细菌感染、耐药与抗菌药物医院感染防控

肠球菌肠道优势与急性白血病化疗人群死亡率增加相关

Enterococcus Intestinal Domination is Associated with Increased Mortality in the Acute Leukemia Chemotherapy Population.
PubMed 文献 · Clin Infect Dis · 2021-12-20

该研究对139例患者的929份每周粪便样本进行16S核糖体RNA基因测序,分析急性白血病化疗队列和异基因造血干细胞移植队列的微生物群组成。肠球菌肠道优势(EID,即肠球菌在微生物群中丰度≥30%)在异基因造血干细胞移植患者中至少一份样本的检出率为36%,在急性白血病患者中为49%。与移植队列相似,发生EID的急性白血病患者总生存期缩短,且EID与两个队列的全因死亡率增加相关。

要点

  • 肠球菌肠道优势指肠球菌在微生物群中丰度≥30%,在急性白血病化疗患者中检出率为49%。
  • 发生肠球菌肠道优势的急性白血病患者总生存期缩短。
  • 其他4个菌属相对丰度≥30%与死亡率无关,而异基因移植中拟杆菌属丰度≥30%与生存改善相关。

核心结论

  • 肠球菌肠道优势与异基因造血干细胞移植队列和急性白血病化疗队列的全因死亡率增加相关。
  • 与肠球菌肠道优势不同,其他菌属相对丰度≥30%与全因死亡率增加无关。

研究设计与样本

  • 研究纳入139例患者,采集929份每周粪便样本,通过16S核糖体RNA基因测序分析微生物群组成。
  • 患者分为两个队列进行分析:急性白血病化疗队列和异基因造血干细胞移植队列。
  • 计算α多样性和丰富度,采用Kaplan-Meier分析评估死亡率。

主要发现

  • 异基因造血干细胞移植队列和急性白血病队列在治疗过程中α多样性和丰富度均下降,且数月后倾向于不恢复至基线。
  • 肠球菌肠道优势在至少一份样本中检出:异基因造血干细胞移植患者为36%,急性白血病患者为49%。
  • 发生肠球菌肠道优势的患者随时间推移α多样性较低。
  • 与移植队列相似,发生肠球菌肠道优势的急性白血病患者总生存期缩短。
  • 鉴定出其他4个菌属在微生物群中相对丰度≥30%常见,但均与死亡率无关;在异基因造血干细胞移植中,拟杆菌属丰度≥30%与生存改善相关。

关键数值与推荐

  • 肠球菌肠道优势定义为肠球菌在微生物群中丰度≥30%。
  • 肠球菌肠道优势在至少一份样本中检出率:异基因造血干细胞移植患者36%,急性白血病患者49%。
  • 其他4个菌属相对丰度≥30%与死亡率无关;异基因造血干细胞移植中拟杆菌属丰度≥30%与生存改善相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Enterococcus intestinal domination (EID), a state of dysbiosis wherein enterococci comprise ≥30% abundance within the microbiota, has been associated with Enterococcus bacteremia, graft-versus-host disease, and mortality in the allogeneic hematopoietic stem cell transplant (allo HCT) population. The acute leukemia (AL) chemotherapy population includes patients receiving intensive chemotherapy but do not all go on to have an allo HCT. The impact of EID on outcomes including mortality in the AL chemotherapy population is unknown. METHODS: Microbiota composition from weekly stool samples was analyzed by 16S ribosomal RNA gene sequencing. Patients were analyzed in 2 cohorts: AL chemotherapy cohort and allo HCT cohort. Alpha-diversity and richness were calculated. Kaplan Meier Analysis was used to analyze mortality. RESULTS: 929 stool samples were collected from 139 patients. Both allo HCT and AL cohorts had a decline in α-diversity and richness over the course of treatment that tends not to return to baseline months later. EID was observed in at least one sample in 36% of allo HCT patients and 49% of AL patients. Patients with observed EID had lower alpha-diversity over time. Similar to the HCT cohort, AL patients with EID had reduced overall survival. We identified 4 other genera that were commonly found in ≥30% relative abundance within the microbiota, but none were associated with mortality. In fact, in allo HCT, Bacteroides abundance ≥30% was associated with improved survival. CONCLUSIONS: EID is associated with increased all-cause mortality in HCT and AL cohorts. UnlikeEID, relative abundance ≥30% by other genera is not associated with increased all-cause mortality.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Messina JA, Tan CY, Ren Y, et al. Enterococcus Intestinal Domination is Associated with Increased Mortality in the Acute Leukemia Chemotherapy Population. Clin Infect Dis. 2021. PMID: 34928341. doi:10.1093/cid/ciab1043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。